GE HealthCare has announced a major expansion of its work with DeepHealth to improve breast cancer detection through artificial intelligence. DeepHealth is a subsidiary of RadNet and focuses on health informatics. The companies first joined forces in 2024 to pair DeepHealth software with the Senographe Pristina mammography system. This new phase will see their combined technologies reach international markets for the first time.
The updated collaboration focuses on the Breast Suite solution. This is a cloud-based set of tools designed to fit into existing clinical workflows. Statistics from a large US study show that using this AI-driven workflow can lead to a 21 per cent increase in cancer detection rates compared to traditional methods. The suite also includes a feature called Timely Alerts which notifies medical staff of suspicious cases within minutes.
Jyoti Gupta, PhD, President and CEO, Women’s Health and X-ray at GE HealthCare, said: “At GE HealthCare, we’re advancing women’s health through precision care built around the unique needs of women and enhanced by the power of AI. By integrating Breast Suite AI with our Pristina Via™ mammography system, we’re helping clinicians detect breast cancer early with greater confidence. These innovations move us closer towards truly personalized prevention and care for women.”
The partnership will now offer specific tools like ProFound Pro and Safeguard Review. ProFound Pro helps with lesion localization and assessing breast density. Safeguard Review is an optional tool that flags complex cases for a second look by a doctor. Research has shown Safeguard Review can increase detection rates by 23% for women with dense breast tissue.
Dr. Meghna Krishnan, Owner, URPrecious Imaging, Arizona, said: “Pristina Via and Breast Suite have transformed how we approach breast cancer detection. The cloud-based viewer gives us instant access to images from anywhere, and the AI tools, like CAD for lesion detection and automated breast density assessment, can help us deliver fast and consistent results. It’s not just about speed, it’s about confidence. With Breast Suite, our team can make more accurate decisions without workflow disruptions, which ultimately means better care for our patients.”
Niccolo Stefani, MD, Business Leader Population Health & Clinical AI, DeepHealth, said: “At DeepHealth, we are committed to bringing the next era of AI-powered health informatics to help stage shift disease. Through our expanded collaboration with GE HealthCare, we are bringing the power of our new Breast Suite to providers around the world to enable early cancer detection, deeper clinical insights, and more confident decisions. Together we are pushing the boundaries of what mammography can deliver, not only for breast cancer screening but for women’s health more broadly.”
GE HealthCare is also debuting other technologies at the 2026 SBI Symposium. These include the Pristina Recon DL for sharper 3D images and the Invenia ABUS Prime for ultrasound screenings.
